Approved for Recurrent or persistent otitis media, Sinusitis, Lower respiratory tract infections. Amoxicillin inhibits cell wall synthesis; clavulanate inhibits beta-lactamase enzymes, extending amoxicillin's spectrum against resistant bacteria. Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels, openFDA FAERS, and CMS NADAC pricing.
Loading full data from Know Your Drugs Institute…